Project Details
Description
Myeloid Leukemia is a very common, but not well understood, disease of the blood system. The proposed research aims to unravel the biology behind the transformation events mediated by the ubiquitin editing enzyme A20. Knowledge obtained from the proposed experiments will provide directions for therapeutics that may aid the treatment of patients with TNFAIP3 mutations.
Status | Finished |
---|---|
Effective start/end date | 1/1/14 → 12/31/15 |
Funding
- Leukemia Research Foundation: US$100,000.00
ASJC Scopus Subject Areas
- Cancer Research
- Oncology
- Biochemistry, Genetics and Molecular Biology(all)
- Medicine(all)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.